Investigator Significant Financial Interests in Research and Disclosure Requirements
"Significant" Financial Interests include the aggregate interests of the investigator and covered family member. Such interests are defined by the Research Conflicts of Interest Policy and include, but are not limited to:
From a publicly traded entity: Compensation for services or other payments (e.g. consulting, advising, lectures, honoraria, paid authorship) in the preceding 12 months and the value of stock, stock options, ownership interests, or rights to such interests held on the date of disclosure, that when aggregated exceeds $5,000. (Does not include interests in mutual funds or retirement accounts.)
From a non-publicly traded entity: Compensation for services in the preceding 12 months that when aggregated exceeds $5,000.
From a non-publicly traded entity: Any amount of stock, stock options, ownership interests, or rights to such interests.
Income from royalties, fees, and rights to such interests from an outside entity other than UTHealth. (Does not include royalties paid by the Office of Technology Management to current UTHealth employees.)
Service as an officer, director, or other fiduciary position for any entity from which the individual received remuneration or payment for expenses in the preceding 12 months.
Gifts received from an outside entity in the preceding 12 months that exceed $250 in value, or multiple gifts from a single entity that in the aggregate exceed $250 in value.
Reimbursed/sponsored travel in the preceding 12 months, if the aggregated value of all payments from the sponsor/organizer (such as salary, consulting fees, honoraria, paid authorship and travel) exceeds $5,000.
When disclosing your interests, you must also disclose the outside activities and financial interests of your Family Members. The term “Family Member” is defined as your spouse, dependent children/step-children, any person financially dependent upon you, and any person with whom you have joint financial interests where your professional responsibilities at UTHealth could affect or be affected by those interests. Researchers must also disclose other significant financial interests not specifically required by the Policy if they have concerns that the activity or interest would appear to affect or be affected by the proposed research. The term “Entity” refers to any organization, company, foundation, trust, or other enterprise.
Individuals of the research team (Covered Individuals) responsible for the design, conduct, or reporting of research must submit an annual UTHealth Financial Disclosure Statement to disclose outside activities and financial interests (of the individual and covered Family Members) as required. UTHealth will review the disclosure and identify the activities and interests that represent "significant" interests (as defined above). A "significant" financial interest that is related to research has the potential to create a financial conflict of interest in research, and requires further review.
The Financial Disclosure Statement should be submitted according to the following schedule:
- Within 30 days of your hire date, covering the prior 12 months;
- Annually (during January-February-March); and
- Within 30 days of any change (e.g., a new activity/interest, a change to an existing activity/interest, or the elimination of an activity/interest).